FeesSafety
Pluang+

Preformed Line Products benefits from $1.4T utility grid investments with strong Q2 growth and margin stability.

Market News
20 Aug 2026, 12:27 WIB
Seeking Alpha
View Source
Bullish
Preformed Line Products benefits from $1.4T utility grid investments with strong Q2 growth and margin stability.

Preformed Line Products is positioned to gain from $1.4 trillion in utility capital expenditures focused on grid transmission and distribution. The company’s strengths include high switching costs, domestic manufacturing, engineering expertise, and quick emergency response, which support strong margins and market share. In Q2, PLPC reported 25% sales growth, a 34.3% gross margin, and 75% earnings per share growth, shifting its outlook from cyclical recovery to sustained higher profitability. The stock is recommended for investors seeking exposure to grid and fiber infrastructure buildout with stable margins and reasonable valuation, with future gains tied to earnings growth and cash flow conversion.

More News

Goldman Sachs forecasts S&P 500 to rise 26% to 8,700 by late 2027 amid tech stock value rebound.

Goldman Sachs forecasts S&P 500 to rise 26% to 8,700 by late 2027 amid tech stock value rebound.

Goldman Sachs predicts the S&P 500 will climb about 26% to 8,700 points within the next 12 months, despite recent market volatility and concerns over AI-driven tech investments. The forecast is supported by lower valuations in tech stocks and a forwa...

Bullish
23 minutes ago
S&P 500 nearly quadrupled investments in 10 years despite recent pullbacks, driven by rising corporate profits.

S&P 500 nearly quadrupled investments in 10 years despite recent pullbacks, driven by rising corporate profits.

Over the past decade, the S&P 500 index has risen 229%, turning a $1,000 investment into nearly $4,000, mainly due to a 212% increase in corporate earnings rather than valuation changes. Despite recent market drops and volatility, holding through pul...

Bullish
45 minutes ago
Bristol Myers Squibb offers a 4.3% yield with strong new drug growth despite upcoming patent risks.

Bristol Myers Squibb offers a 4.3% yield with strong new drug growth despite upcoming patent risks.

Bristol Myers Squibb, a major pharmaceutical company, currently offers a 4.3% dividend yield and trades at a price-to-earnings ratio well below the industry average. Its newer drug portfolio generated nearly $7.7 billion in revenue last quarter, grow...

Market News
Bullish
53 minutes ago
Nvidia stock plunges 43% after CEO Jensen Huang resigns amid scandal, but analyst sees 65% upside ahead.

Nvidia stock plunges 43% after CEO Jensen Huang resigns amid scandal, but analyst sees 65% upside ahead.

Nvidia's stock has dropped about 43% following CEO Jensen Huang's sudden resignation linked to alleged Chinese intelligence ties, wiping out over $2.5 trillion in market value. Despite concerns about leadership loss, analyst Dan Ives believes Nvidia'...

Market News
Bearish
58 minutes ago
ASUS launches holiday sale with up to 44% off laptops and desktops until Dec 2, 2026

ASUS launches holiday sale with up to 44% off laptops and desktops until Dec 2, 2026

ASUS has announced a holiday sale offering discounts up to 44% on a wide range of laptops and desktops, available online and in stores like Best Buy until December 2, 2026. The sale features budget-friendly options like the ASUS Vivobook 14 starting ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App